EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

A Randomized, Phase 3, Double-Blind, Crossover Comparison of Multilayer, Extended-Release Methylphenidate (PRC-063), and Lisdexamfetamine in the Driving Performance of Young Adults With ADHD

Vishal Madaan, Sailaja Bhaskar, Graeme A E Donnelly iD, Daniel J Cox

Journal of Attention Disorders · 2024-04 · 28 (6) · 947-956

DOI: 10.1177/10870547241226634 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift Journal of Attention Disorders, online erschienen am 25.02.2024. Verfasst von Vishal Madaan und 3 weiteren Autor:innen. Beteiligte Einrichtung: American Psychiatric Association, Washington, DC, USA. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Central Nervous System Stimulants, Methylphenidate. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare PRC-063 (multilayer-release methylphenidate) and lisdexamfetamine dimesylate (LDX) on the driving performance of young adults with attention deficit hyperactivity disorder (ADHD) in a randomized, double-blind, crossover study.

Method

Following up to 21 days of each treatment in each treatment course (PRC-063/LDX or LDX/PRC-063), subjects completed a 15-hour driving simulator laboratory assessment. The primary outcome measure was the Tactical Driving Quotient (TDQ) and the Clinical Global Impressions-Improvement (CGI-I) scale was a secondary outcome measure.

Results

Forty-four subjects completed the study. PRC-063 and LDX had equivalent effects on driving performance through a 15-hour time period (least square mean difference −0.3 [standard error 1.08], 95% confidence interval [−2.4, 1.8], p = .793). Consistent improvement in CGI-I was observed. The incidence of treatment-emergent adverse events was similar for each treatment sequence.

Conclusions

PRC-063 and LDX had comparable effects on driving performance, from 1 through 15 hours, the last time point measured.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Attention Deficit Disorder with HyperactivityCentral Nervous System StimulantsMethylphenidateHumansYoung AdultCross-Over StudiesDose-Response Relationship, DrugDouble-Blind MethodLisdexamfetamine DimesylateTreatment Outcome

Stichwörter der Autor:innen

ADHDPRC-063lisdexamfetamine dimesylatemethylphenidatesimulated driving performance

Substanzen

Central Nervous System StimulantsLisdexamfetamine DimesylateMethylphenidate

Autor:innen und Institutionen

  • American Psychiatric Association, Washington, DC, USA.
  • Imbrium Therapeutics L.P., A Subsidiary of Purdue Pharma L.P., Stamford, CT, USA.
  • Elvium Life Sciences, Toronto, ON, Canada.
  • University of Virginia Health System, Charlottesville, USA.

ORCID-Profile: Graeme A E Donnelly

Zitieren

APA

Madaan, V., Bhaskar, S., Donnelly, G. A. E., & Cox, D. J. (2024). A Randomized, Phase 3, Double-Blind, Crossover Comparison of Multilayer, Extended-Release Methylphenidate (PRC-063), and Lisdexamfetamine in the Driving Performance of Young Adults With ADHD. Journal of Attention Disorders, 28(6), 947-956. https://doi.org/10.1177/10870547241226634

Vancouver

Madaan V, Bhaskar S, Donnelly GAE, Cox DJ. A Randomized, Phase 3, Double-Blind, Crossover Comparison of Multilayer, Extended-Release Methylphenidate (PRC-063), and Lisdexamfetamine in the Driving Performance of Young Adults With ADHD. Journal of Attention Disorders. 2024;28(6):947-956. doi:10.1177/10870547241226634

BibTeX
@article{Madaan2024,
  author = {Madaan, Vishal and Bhaskar, Sailaja and Donnelly, Graeme A E and Cox, Daniel J},
  title = {A Randomized, Phase 3, Double-Blind, Crossover Comparison of Multilayer, Extended-Release Methylphenidate (PRC-063), and Lisdexamfetamine in the Driving Performance of Young Adults With ADHD},
  journal = {Journal of Attention Disorders},
  year = {2024},
  volume = {28},
  number = {6},
  pages = {947--956},
  doi = {10.1177/10870547241226634}
}
Kostenlos starten →